Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interferon-free Treatment of Acute Genotype 1 Hepatitis C Virus Infection With Ledipasvir/Sofosbuvir Fixed-Dose Combination - The HepNet Acute HCV IV Study

NCT02309918 is registered in ClinicalTrials.gov with HepNet Study House, German Liverfoundation as lead sponsor.

NCT NCT02309918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02309918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interferon-free Treatment of Acute Genotype 1 Hepatitis C Virus Infection With Ledipasvir/Sofosbuvir Fixed-Dose Combination - The HepNet Acute HCV IV Study
Lead sponsor
HepNet Study House, German Liverfoundation
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2014
Completion date
August 31, 2016
Enrollment
20 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

acute hepatitis c